AMN Healthcare Services (AMN)
(Delayed Data from NYSE)
$41.01 USD
-1.41 (-3.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.01 USD
-1.41 (-3.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
Zacks News
AMN Stock Down Despite WorkWise Launch to Enhance Healthcare Delivery
by Zacks Equity Research
AMN Healthcare aims to enhance staffing efficiency and improve operational efficiency in healthcare systems via the latest launch.
Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio
by Zacks Equity Research
AMN shows growth potential with its broad services and high demand but faces challenges from industry regulations and strong competition in the staffing space.
Alignment Healthcare (ALHC) Moves 12.7% Higher: Will This Strength Last?
by Zacks Equity Research
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Is the Options Market Predicting a Spike in AMN Healthcare (AMN) Stock?
by Zacks Equity Research
Investors need to pay close attention to AMN Healthcare (AMN) stock based on the movements in the options market lately.
AMN Healthcare (AMN) Q2 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall second-quarter performance.
Compared to Estimates, AMN Healthcare (AMN) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMN Healthcare Services (AMN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 30.67% and 0.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Wall Street's Insights Into Key Metrics Ahead of AMN Healthcare (AMN) Q2 Earnings
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for AMN Healthcare (AMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.
AMN Healthcare (AMN) Unveils ShiftWise Flex Manager Hub App
by Zacks Equity Research
AMN Healthcare's (AMN) Manager Hub app, part of the ShiftWise Flex platform, revolutionizes workforce management for healthcare organizations with enhanced mobile capabilities and comprehensive insights.
J.Jill, and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
J.Jill, and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
Bear of the Day: AMN Healthcare (AMN)
by Tracey Ryniec
When will travel nurse demand return?
New Strong Sell Stocks for June 26th
by Zacks Equity Research
AMN, ALNT and DNZOY have been added to the Zacks Rank #5 (Strong Sell) List on June 26, 2024.
New Strong Sell Stocks for June 4th
by Zacks Equity Research
AMN, ARCB and ARW have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2023.
Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
AMN Healthcare (AMN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Compared to Estimates, AMN Healthcare (AMN) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AMN Healthcare Services (AMN) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.30% and 0.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for AMN Healthcare (AMN) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of AMN Healthcare (AMN) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: AMN Healthcare Services (AMN) Q1 Earnings Expected to Decline
by Zacks Equity Research
AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 30th
by Zacks Equity Research
AFCG, AAGIY and AMN have been added to the Zacks Rank #5 (Strong Sell) List on April 30, 2023.
New Strong Sell Stocks for April 22nd
by Zacks Equity Research
AMN, PRG and RKDA have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2024.
New Strong Sell Stocks for April 11th
by Zacks Equity Research
AMN, ACLS and GME have been added to the Zacks Rank #5 (Strong Sell) List on April 11, 2024.
Teladoc Health (TDOC) Down 1.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Teladoc Health (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Kaiser Aluminum and AMN Healthcare Services have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Kaiser Aluminum and AMN Healthcare Services are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: AMN Healthcare Services (AMN)
by Shaun Pruitt
Labor shortages and staff burnout among nurses are reasons to be wary of AMN Healthcare Services (AMN) stock despite the company's favorable long-term prospects.